ATE360608T1 - Verfahren zur herstellung von 1,3-diolen - Google Patents

Verfahren zur herstellung von 1,3-diolen

Info

Publication number
ATE360608T1
ATE360608T1 AT98961855T AT98961855T ATE360608T1 AT E360608 T1 ATE360608 T1 AT E360608T1 AT 98961855 T AT98961855 T AT 98961855T AT 98961855 T AT98961855 T AT 98961855T AT E360608 T1 ATE360608 T1 AT E360608T1
Authority
AT
Austria
Prior art keywords
diols
producing
Prior art date
Application number
AT98961855T
Other languages
English (en)
Inventor
Richard Joseph Mccabe
Thomas Norman Nanninga
Robert Lee Bosch
Robert Joseph Stahl
Original Assignee
Pfizer Ireland Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ireland Pharmaceuticals filed Critical Pfizer Ireland Pharmaceuticals
Application granted granted Critical
Publication of ATE360608T1 publication Critical patent/ATE360608T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/19—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and carboxyl groups, other than cyano groups, bound to the same saturated acyclic carbon skeleton
    • C07C255/20—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and carboxyl groups, other than cyano groups, bound to the same saturated acyclic carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/40—2,5-Pyrrolidine-diones
    • C07D207/416—2,5-Pyrrolidine-diones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B41/00—Formation or introduction of functional groups containing oxygen
    • C07B41/02—Formation or introduction of functional groups containing oxygen of hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/19—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and carboxyl groups, other than cyano groups, bound to the same saturated acyclic carbon skeleton
    • C07C255/21—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and carboxyl groups, other than cyano groups, bound to the same saturated acyclic carbon skeleton the carbon skeleton being further substituted by doubly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Pyrrole Compounds (AREA)
AT98961855T 1997-12-19 1998-12-02 Verfahren zur herstellung von 1,3-diolen ATE360608T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6819397P 1997-12-19 1997-12-19

Publications (1)

Publication Number Publication Date
ATE360608T1 true ATE360608T1 (de) 2007-05-15

Family

ID=22081016

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98961855T ATE360608T1 (de) 1997-12-19 1998-12-02 Verfahren zur herstellung von 1,3-diolen

Country Status (31)

Country Link
US (4) US6433213B1 (de)
EP (1) EP1054860B1 (de)
JP (1) JP2001526256A (de)
KR (2) KR100681366B1 (de)
AR (1) AR014943A1 (de)
AT (1) ATE360608T1 (de)
AU (1) AU755543B2 (de)
BR (1) BR9813760A (de)
CA (1) CA2305618C (de)
CO (1) CO4990941A1 (de)
CU (1) CU22939A3 (de)
CY (1) CY1106612T1 (de)
DE (1) DE69837681T2 (de)
DK (1) DK1054860T3 (de)
ES (1) ES2284219T3 (de)
GT (2) GT199800197A (de)
HN (1) HN1998000187A (de)
HU (1) HUP0100252A3 (de)
IL (1) IL135562A (de)
IS (1) IS5447A (de)
MY (1) MY118726A (de)
NO (1) NO20003139L (de)
NZ (1) NZ504346A (de)
PA (1) PA8464901A1 (de)
PE (1) PE20000136A1 (de)
PL (1) PL193678B1 (de)
PT (1) PT1054860E (de)
SV (1) SV1998000153A (de)
TW (1) TW444000B (de)
WO (1) WO1999032434A1 (de)
ZA (1) ZA9811586B (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL149088A0 (en) 1999-12-17 2002-11-10 Warner Lambert Res & Dev Ie A process for producing crystalline atorvastatin calcium
DE60024133T2 (de) 1999-12-17 2006-08-03 Pfizer Science And Technology Ireland Ltd., Dun Laoghaire Herstellungsverfahren auf industrieller basis von atorvastatin trihydrat hemi-kalziumsalz in kristalliner form
US7300775B2 (en) 1999-12-29 2007-11-27 Verenium Corporation Methods for producing α-substituted carboxylic acids using nitrilases and strecker reagents
US20040014195A1 (en) * 1999-12-29 2004-01-22 Diversa Corporation Nitrilases, nucleic acids encoding them and methods for making and using them
US7608445B1 (en) 1999-12-29 2009-10-27 Verenium Corporation Nitrilases, nucleic acids encoding them and methods for making and using them
US7521216B2 (en) 1999-12-29 2009-04-21 Verenium Corporation Nitrilases and methods for making and using them
EP1375485B1 (de) 2001-04-05 2011-04-20 Nissan Chemical Industries, Ltd. Verfahren zur herstellung von 7-chinolinyl-3,5-dihydroxyhept-6-enoat
SK802004A3 (en) 2001-07-06 2004-10-05 Teva Pharma Process for the preparation of 7-amino syn 3,5-dihydroxy heptanoic acid derivatives via 6-cyano syn 3,5-dihydroxy hexanoic acid derivatives
DE60235365D1 (de) * 2001-07-06 2010-04-01 Basf Se Verfahren zur herstellung von 7-amino-syn-3,5-dihydroxyheptansäurederivaten und zwischenverbindungen diesesverfahrens und deren herestellung
GB0211715D0 (en) * 2002-05-22 2002-07-03 Phoenix Chemicals Ltd Process
WO2003106415A2 (en) * 2002-06-13 2003-12-24 Diversa Corporation Processes for making (r)-ethyl 4-cyano-3-hydroxybutyric acid
CA2493941A1 (en) * 2002-08-09 2004-02-19 Codexis, Inc. Enzymatic processes for the production of 4-substituted 3-hydroxybutyric acid derivatives
DE60326654D1 (de) * 2003-04-22 2009-04-23 Biocon Ltd Neues verfahren zur stereoselektiven reduktion von beta-ketoestern
US7790197B2 (en) * 2003-06-09 2010-09-07 Warner-Lambert Company Llc Pharmaceutical compositions of atorvastatin
US20040253305A1 (en) * 2003-06-12 2004-12-16 Luner Paul E. Pharmaceutical compositions of atorvastatin
US7655692B2 (en) * 2003-06-12 2010-02-02 Pfizer Inc. Process for forming amorphous atorvastatin
US20050271717A1 (en) 2003-06-12 2005-12-08 Alfred Berchielli Pharmaceutical compositions of atorvastatin
US7588928B2 (en) * 2003-08-11 2009-09-15 Codexis, Inc. Halohydrin dehalogenases and related polynucleotides
KR20060064620A (ko) * 2003-08-11 2006-06-13 코덱시스, 인코포레이티드 개선된 글루코스 데히드로게나제 폴리펩티드 및 관련폴리뉴클레오티드
MXPA06001718A (es) 2003-08-11 2006-05-19 Codexis Inc Procedimiento enzimatico para la produccion de derivados de acido 3-hidroxibutirico 4-sustituido y esteres de acido carboxilico sustituido con ciano e hidroxi vecinales.
US7541171B2 (en) * 2003-08-11 2009-06-02 Codexis, Inc. Halohydrin dehalogenases and related polynucleotides
CA2533838A1 (en) * 2003-08-11 2005-02-24 Codexis, Inc. Improved ketoreductase polypeptides and related polynucleotides
CA2535255A1 (en) * 2003-08-11 2005-02-24 Codexis, Inc. Improved halohydrin dehalogenases and related polynucleotides
US20070276027A1 (en) * 2003-09-17 2007-11-29 Warner-Lambert Company Llc Crystalline Forms of [R-(R* ,R*)]-2-(4-Fluorophenyl)-Beta, -Dihydroxy-5-(1-Methylethyl)-3-Phenyl-4-[(Phenylamino)Carbonyl]-1H-Pyrrole-1-Heptanoic Acid
WO2005026107A1 (en) * 2003-09-18 2005-03-24 Biocon Limited Novel process for the preparation of tert-butyl 6-cyano-5-hydroxy-3-oxohexanoate
US7851624B2 (en) * 2003-12-24 2010-12-14 Teva Pharamaceutical Industries Ltd. Triol form of rosuvastatin and synthesis of rosuvastatin
US20050159615A1 (en) * 2003-12-24 2005-07-21 Entire Interest. Process for preparation of statins with high syn to anti ratio
US20070225353A1 (en) * 2004-04-16 2007-09-27 Pfizer, Inc. Process for Forming Amorphous Atorvastatin
EP2540704B1 (de) 2004-05-05 2019-07-03 Pfizer Products Inc. Formen von Atorvastatinsalzen mit Benethamin
RU2412191C2 (ru) * 2004-07-16 2011-02-20 Лек Фармасьютиклз Д.Д. Продукты окислительной деструкции кальций аторвастатина
US8026376B2 (en) 2004-07-20 2011-09-27 Pfizer, Inc. Forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoicacid calcium salt (2:1)
JP2008517992A (ja) 2004-10-28 2008-05-29 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー アモルファスのアトルバスタチンを形成する方法
ATE439347T1 (de) 2004-11-23 2009-08-15 Warner Lambert Co 7-(2h-pyrazol-3-yl)-3,5-dihydroxy-heptansäure- derivate als hmg-co-a-reductase-inhibitoren zur behandlung von lipidemia
CA2589537A1 (en) * 2004-12-02 2006-06-08 Stephen Craig Dyar Pharmaceutical compositions of amorphous atorvastatin and process for preparing same
EP1922301A1 (de) * 2005-09-09 2008-05-21 Pfizer Science and Technology Ireland Limited Herstellung eines atorvastatin-zwischenprodukts
EP1922315B1 (de) * 2005-09-09 2009-05-27 Pfizer Science and Technology Ireland Limited Herstellung eines atorvastatin-zwischenprodukts
CA2547216A1 (en) 2005-09-21 2007-03-21 Renuka D. Reddy Process for annealing amorphous atorvastatin
US8084488B2 (en) 2005-11-21 2011-12-27 Pfizer Inc. Forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid magnesium
WO2008042876A2 (en) 2006-10-02 2008-04-10 Codexis, Inc. Compositions and methods for producing stereoisomerically pure statins and synthetic intermediates therefor
EP2115153B1 (de) 2007-03-01 2013-06-05 BP Corporation North America Inc. Nitrilasen, dafür kodierende nukleinsäuren sowie verfahren zu ihrer herstellung und verwendung
WO2009137691A2 (en) * 2008-05-09 2009-11-12 The Scripps Research Institute 1,3-diol synthesis via controlled, radical-mediated c-h functionalization
US8187856B2 (en) * 2008-12-18 2012-05-29 Codexis, Inc. Recombinant halohydrin dehalogenase polypeptides
EP2373609B1 (de) 2008-12-19 2013-10-16 KRKA, D.D., Novo Mesto Verwendung amphiphiler verbindungen zur kontrollierten kristallisation von statinen und statinzwischenprodukten
EP2327682A1 (de) 2009-10-29 2011-06-01 KRKA, D.D., Novo Mesto Verwendung von amphiphilen Verbindungen zur gesteuerten Kristallisation von Statinen und Statin Zwischenprodukte.
WO2012158833A2 (en) * 2011-05-16 2012-11-22 The Regents Of The University Of California Methods for production of hydrocarbons and oxygen-containing hydrocarbons
WO2013004591A1 (en) 2011-07-01 2013-01-10 Dsm Sinochem Pharmaceuticals Netherlands B.V. Micronized crystals of atorvastatin hemicalcium
CN108033899B (zh) * 2017-12-06 2020-04-10 浙江科技学院 一种(r)-6-氰基-5-羟基-3-羰基己酸叔丁酯的制备方法
CN111978286A (zh) * 2020-08-21 2020-11-24 江苏万年长药业有限公司 一种制备ats-8的方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR64043B (en) 1977-10-01 1980-01-19 Expansia Sa Borane complexes
DE2912708A1 (de) 1979-03-30 1980-10-09 Basf Ag Datenspeichersystem und magnetscheiben dafuer
US5169857A (en) * 1988-01-20 1992-12-08 Bayer Aktiengesellschaft 7-(polysubstituted pyridyl)-hept-6-endates useful for treating hyperproteinaemia, lipoproteinaemia or arteriosclerosis
US5354772A (en) 1982-11-22 1994-10-11 Sandoz Pharm. Corp. Indole analogs of mevalonolactone and derivatives thereof
US4645854A (en) * 1985-04-25 1987-02-24 Merck & Co., Inc. Process for preparing HMG-CoA reductase inhibitors with a 3,5-dihydroxypentanoate subunit
US4898949A (en) * 1987-02-25 1990-02-06 Bristol-Myers Company Intermediates for the preparation of antihypercholesterolemic tetrazole compounds
US4897490A (en) * 1987-02-25 1990-01-30 Bristol-Meyers Company Antihypercholesterolemic tetrazole compounds
DE3741509A1 (de) 1987-12-08 1989-06-22 Hoechst Ag Verfahren zur herstellung optisch aktiver 3-desmethylmevalonsaeurederivate sowie zwischenprodukte
US5001144A (en) * 1987-12-21 1991-03-19 Rhone-Poulenc Rorer Pharmaceuticals Inc. Substituted cyclohexene derivatives as HMG-CoA reductase inhibitors
US5003080A (en) * 1988-02-22 1991-03-26 Warner-Lambert Company Process for trans-6-(2-(substituted-pyrrol-1-yl)alkyl)pryan-2-one inhibitors of cholesterol synthesis
FR2642065B1 (fr) * 1989-01-24 1991-05-24 Lipha Derives d'acides benzocycloalcenyl dihydroxy alcanoiques, procede de preparation et medicaments les contenant
FI94339C (fi) * 1989-07-21 1995-08-25 Warner Lambert Co Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
DE3929507A1 (de) * 1989-09-06 1991-03-07 Bayer Ag Substituierte amino-pyridine
US5039802A (en) 1990-04-18 1991-08-13 Merck & Co., Inc. Arylation process for preparation of chiral catalysts for ketone reduction
JP3528186B2 (ja) * 1991-06-24 2004-05-17 日産化学工業株式会社 光学活性キノリンメバロン酸のジアステレオマー塩
US5155251A (en) 1991-10-11 1992-10-13 Warner-Lambert Company Process for the synthesis of (5R)-1,1-dimethylethyl-6-cyano-5-hydroxy-3-oxo-hexanoate
US5218138A (en) * 1992-09-02 1993-06-08 Rhone-Poulenc Rorer Pharmaceuticals Inc. Stereoselective reduction of 3-hydroxyket-1-ones to 1,3-syn-dihydroxylated compounds
US5298627A (en) * 1993-03-03 1994-03-29 Warner-Lambert Company Process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis

Also Published As

Publication number Publication date
IL135562A (en) 2005-08-31
HUP0100252A1 (hu) 2001-07-30
US7232915B2 (en) 2007-06-19
PA8464901A1 (es) 2000-05-24
IL135562A0 (en) 2001-05-20
US20040006231A1 (en) 2004-01-08
SV1998000153A (es) 1999-09-30
PL341294A1 (en) 2001-04-09
CA2305618A1 (en) 1999-07-01
ZA9811586B (en) 1999-06-17
EP1054860A1 (de) 2000-11-29
PT1054860E (pt) 2007-06-22
MY118726A (en) 2005-01-31
TW444000B (en) 2001-07-01
WO1999032434A1 (en) 1999-07-01
JP2001526256A (ja) 2001-12-18
EP1054860B1 (de) 2007-04-25
DE69837681D1 (de) 2007-06-06
CO4990941A1 (es) 2000-12-26
NO20003139D0 (no) 2000-06-16
NO20003139L (no) 2000-06-16
GT199800197AA (es) 2000-06-06
AU755543B2 (en) 2002-12-12
US20020161021A1 (en) 2002-10-31
DK1054860T3 (da) 2007-07-02
KR100668575B1 (ko) 2007-01-17
IS5447A (is) 2000-04-14
CY1106612T1 (el) 2012-01-25
KR20060080941A (ko) 2006-07-11
KR20010033315A (ko) 2001-04-25
CA2305618C (en) 2004-08-17
US20050197500A1 (en) 2005-09-08
BR9813760A (pt) 2000-10-03
HUP0100252A3 (en) 2002-12-28
PE20000136A1 (es) 2000-03-11
AR014943A1 (es) 2001-04-11
US6596879B2 (en) 2003-07-22
DE69837681T2 (de) 2008-01-10
KR100681366B1 (ko) 2007-02-12
GT199800197A (es) 2000-06-06
AU1707499A (en) 1999-07-12
CU22939A3 (es) 2004-04-13
US6962994B2 (en) 2005-11-08
PL193678B1 (pl) 2007-03-30
US6433213B1 (en) 2002-08-13
ES2284219T3 (es) 2007-11-01
NZ504346A (en) 2001-11-30
HN1998000187A (es) 1999-10-22

Similar Documents

Publication Publication Date Title
ATE360608T1 (de) Verfahren zur herstellung von 1,3-diolen
DE69801489D1 (de) Verfahren zur herstellung von 1,1,1,3,3-pentafluorpropan
DE69620461D1 (de) Verfahren zur herstellung von 1,1,1,3,3,-pentafluoropropanen
DE69512250D1 (de) Verfahren zur herstellung von 1,1,1,3,3,3- hexafluorpropan
DE69618476D1 (de) Verfahren zur herstellung von 1,1,1,3,3-pentafluorpropan
DE69711669D1 (de) VERFAHREN ZUR HERSTELLUNG VON d,1-ALPHA-TOCOPHEROL
ATE339433T1 (de) Verbessertes verfahren zur herstellung von makroliden
DE69726441D1 (de) Verfahren zur herstellung von 1,3-dioxolan-4-methanol-verbindungen
DE59906265D1 (de) Verfahren zur herstellung von 1,4-butandiol
DE69510087D1 (de) Verfahren zur herstellung von 5-chlor-2,3-dihydro-1h-inden-1-on
DE59901552D1 (de) Verfahren zur herstellung von polyalkylenarylaten
DE69910995D1 (de) Verfahren zur herstellung von fluorkohlenwasserstoffen
DE59905197D1 (de) Verfahren zur herstellung von hexandiol-1,6
DE69717115D1 (de) Verfahren zur herstellung von 1,1,1,3,3-pentafluorpropan
DE69724442D1 (de) Verfahren zur herstellung von 1,3-dioxolan-4-methanol-verbindungen
ATE366251T1 (de) Verfahren zur herstellung von 1,3- disubstituierten-4-oxocyclischen harnstoffen
DE69603261D1 (de) Verfahren zur herstellung von 1,2-benzisothiazolonen
DE69711039D1 (de) Verfahren zur herstellung von 1,3-alkandiolen
DE69819191D1 (de) Verfahren zur herstellung von pentafluorethan
ATE225797T1 (de) Verfahren zur herstellung von oxazaphosphorin-2- aminen
DE69631154D1 (de) Verfahren zur herstellung von 1,1,1,3,3-pentafluorpropan
ATE275563T1 (de) Verfahren zur herstellung von 1,3- disubstituierten-4-oxocyclischen harnstoffen
DE69733152D1 (de) Verfahren zur herstellung von tetrazolylbenzopyranen
DE69811100D1 (de) Verfahren zur herstellung von 1,2-propandiol
DE59802764D1 (de) Verfahren zur herstellung von phosphabenzolverbindungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1054860

Country of ref document: EP

REN Ceased due to non-payment of the annual fee